Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

truthseeeker Aug. 16 at 7:16 PM

$PFE to the poster predicting $30 by year end. < a dose of PFE reality is in order. Realistic knowledgeable PFE holders/investors/traders will be plenty happy if PFE holds $26 and does not do a patented PFE drawdown to below 25.

1 · Reply

AskLou Aug. 16 at 6:52 PM

$ZTS what happened here? I never understood the premium valuation when it was spun from $PFE but what happened? Earning growth is flat but cash flow is excellent. Has private equity sucked all the discretionary cash out of the vet industry?

0 · Reply

Antipig Aug. 16 at 3:03 PM

$MRNA $PFE https://www.zerohedge.com/covid-19/fauci-hiding-abc-censorship-bombshell-explodes?utm_source=daily_newsletter&utm_medium=email&utm_campaign=8938

0 · Reply

grampslol Aug. 16 at 1:01 PM

$MNKD poor pumper cultist @clan a deluding himself as he tries to deceive the naive $NVS $SNY $PFE

0 · Reply

clan Aug. 16 at 12:42 PM

$MNKD Mannkind Corp. is in the game. "goal!" 🥅🏒 "Goal!" 🥅🏒 "GOAL!" 🥅🏒 Next partner? #thefixisin #inhalemyinsulin #insulinthemoment 💪 $PFE 🇺🇲 $NVS 👀 $SNY 💪

1 · Reply

Negi69 Aug. 16 at 9:39 AM

$VALN $PFE when comes the lyme fomo? There was low volume for this news at friday

0 · Reply

PAHANA Aug. 15 at 9:48 PM

Monday morning long positions Recession proof $DG 380 dollar price target 36 months $TLT 180 dollar target 5 years $PFE 60 dollar target 30 months $GIS 90 dollars 24 months $TSLA 180 dollars 20 months protect your self before you wreck your self, mark it a new day a new trade, see you Monday

1 · Reply

JuggernautRaider Aug. 15 at 8:59 PM

Digital is here to stay and the blockchain standard can be improved. No more 💩 coin, the governments can have their own ledges soon enough 🏦 $BITC $PFE $BMY $GILD

0 · Reply

peloswing Aug. 15 at 7:24 PM

In just 10 days, $PFE rose over +6.7% since this chart! BUT, is the run over or just beginning?! 🤔 After breaking over the 200WMA and weekly resistance trendline, a hold of support at $26.25 can see a continuation! 📈

0 · Reply

Blueviking Aug. 15 at 7:01 PM

$NWBO $GNS $TSLA $PFE $SPCX

0 · Reply

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Aug 14, 2026, 11:46 AM EDT - 2 days ago

Closed Pfizer biopharma facility in Everett gets a new lease on life

Aug 14, 2026, 11:11 AM EDT - 2 days ago

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

Aug 14, 2026, 1:00 AM EDT - 2 days ago

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

VALN

Aug 4, 2026, 10:00 AM EDT - 12 days ago

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 12 days ago

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 12 days ago

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 12 days ago

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 7:24 AM EDT - 12 days ago

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:13 AM EDT - 12 days ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:12 AM EDT - 12 days ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Aug 4, 2026, 6:52 AM EDT - 12 days ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:45 AM EDT - 12 days ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Aug 3, 2026, 8:10 AM EDT - 13 days ago

5 Things to Know Before the Stock Market Opens on Monday

AMD AZN BMY CAT CVS DASH DIS

Jul 30, 2026, 7:48 AM EDT - 17 days ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 6:45 AM EDT - 17 days ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 29, 2026, 4:30 PM EDT - 18 days ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Jul 22, 2026, 4:48 PM EDT - 25 days ago

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:30 PM EDT - 25 days ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 21, 2026, 7:10 PM EDT - 25 days ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Jul 16, 2026, 1:39 PM EDT - 4 weeks ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 10, 2026, 11:23 AM EDT - 5 weeks ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 6, 2026, 10:00 AM EDT - 5 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jun 29, 2026, 4:43 PM EDT - 6 weeks ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Jun 29, 2026, 1:20 AM EDT - 6 weeks ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 24, 2026, 3:52 PM EDT - 7 weeks ago

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 2:10 PM EDT - 7 weeks ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 10:51 AM EDT - 7 weeks ago

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 23, 2026, 12:10 PM EDT - 7 weeks ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 22, 2026, 4:43 PM EDT - 7 weeks ago

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:30 PM EDT - 7 weeks ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 2:32 PM EDT - 7 weeks ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 2 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 2 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 31, 2026, 8:00 AM EDT - 2 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 8:00 AM EDT - 2 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 29, 2026, 8:00 AM EDT - 2 months ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 28, 2026, 11:10 PM EDT - 2 months ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 7:19 PM EDT - 2 months ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:00 PM EDT - 2 months ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

truthseeeker Aug. 16 at 7:16 PM

1 · Reply

AskLou Aug. 16 at 6:52 PM

0 · Reply

Antipig Aug. 16 at 3:03 PM

$MRNA $PFE https://www.zerohedge.com/covid-19/fauci-hiding-abc-censorship-bombshell-explodes?utm_source=daily_newsletter&utm_medium=email&utm_campaign=8938

0 · Reply

grampslol Aug. 16 at 1:01 PM

$MNKD poor pumper cultist @clan a deluding himself as he tries to deceive the naive $NVS $SNY $PFE

0 · Reply

clan Aug. 16 at 12:42 PM

$MNKD Mannkind Corp. is in the game. "goal!" 🥅🏒 "Goal!" 🥅🏒 "GOAL!" 🥅🏒 Next partner? #thefixisin #inhalemyinsulin #insulinthemoment 💪 $PFE 🇺🇲 $NVS 👀 $SNY 💪

1 · Reply

Negi69 Aug. 16 at 9:39 AM

$VALN $PFE when comes the lyme fomo? There was low volume for this news at friday

0 · Reply

PAHANA Aug. 15 at 9:48 PM

1 · Reply

JuggernautRaider Aug. 15 at 8:59 PM

Digital is here to stay and the blockchain standard can be improved. No more 💩 coin, the governments can have their own ledges soon enough 🏦 $BITC $PFE $BMY $GILD

0 · Reply

peloswing Aug. 15 at 7:24 PM

0 · Reply

Blueviking Aug. 15 at 7:01 PM

$NWBO $GNS $TSLA $PFE $SPCX

0 · Reply

Lowkeyoptions Aug. 15 at 4:03 PM

$TENX adding up the numbers from the sc 13G i get 20 million shares about hedgefund holdings as of last reporting August 14th. Imo that's very sizeable and if they took a dive down we're in for a wild ride. $CAPR $RGC $DRUG $PFE

0 · Reply

Lowkeyoptions Aug. 15 at 10:44 AM

$TENX watching bashers go bullish here is funny. Those 13g filings all dropped ah and i feel that was on purpose. Count up the millions held now plus company shares held. $CAPR $RGC $DRUG $PFE

1 · Reply

GordoHLYK13 Aug. 15 at 7:58 AM

$IGC That’s a 6-year-old, fully resolved SEC matter—not a current investigation or operational issue. The business has completely transformed from its 2020 infrastructure/cannabis roots into IGC Pharma, a clinical-stage biotech focused on Alzheimer’s. Today, the story is Phase 2 CALMA, IGC-AD1, and the upcoming Q4 2026 data—not recycled 2020 paperwork. Bringing up ancient, settled filings to create fresh fear is noise. Watch the clinical data, not the archives. $IGC 🚀📈 $PFE $ABBV $MRNA Shorts are digging deep for old narratives—looks like fear is building ahead of IGC’s Phase 2 results. The closer we get to the data, the louder the noise gets. $IGC 🚀📈

1 · Reply

Trade111222 Aug. 15 at 1:30 AM

$PFE back to 25.5 next week or below

0 · Reply

Lowkeyoptions Aug. 14 at 11:14 PM

$TENX 4 new 13G just dropped nothing left for retail 1.6 million 2.9 million 1.4 million 3.4 million 9 million 1.6 million Do the maths on this insider load Wtf!! 118 million in cash $CAPR $RGC $DRUG $PFE

1 · Reply

Bob67_ Aug. 14 at 10:50 PM

$ELTP $GME $META $PFE Nope.

0 · Reply

JBS_84 Aug. 14 at 9:37 PM

$PFE I expect sideways consolidation for a bit

0 · Reply

Micheal_Pothead Aug. 14 at 9:04 PM

$PFE just a PSA, we crossed the 200 week moving average last week and held it this week

1 · Reply

Micheal_Pothead Aug. 14 at 7:45 PM

$PFE shorts are mad

0 · Reply

Micheal_Pothead Aug. 14 at 7:14 PM

$PFE 27.01 close would confirm 30 imo

2 · Reply

BarkingPuppy Aug. 14 at 7:05 PM

$ELTP $DJT $GME $PFE $JNJ The Rumors in the Bio-tech world are going crazy. Who is going to Grab ELTP in America Before a Foreign Company Buys them???? I would like to keep it in American Hands, I think their ART technology is far to great and powerful to let a none US company acquire this There is no official corporate announcement or confirmed agreement that Elite Pharmaceuticals (ELTP) is being bought by a foreign buyer. Online retail investor communitie have heavily speculated about a potential company buyout—including theories involving international or foreign acquirers motivated by manufacturing capacities or tariff strategies. However, these claims remain unverified market speculation and rumor rather than official business operations. The company's management has previously discussed a sale or buyout as a strategic option to maximize shareholder value or address listing requirements, but no foreign acquisition deal has been finalized or announced.

0 · Reply

GordoHLYK13 Aug. 14 at 6:34 PM

$IGC Pay attention—you're about to see a late-session surge right before the closing bell. Supporting Factors for Late-Day Moves Institutional MOC Orders: Market-On-Close (MOC) imbalance data is released in the final 20–30 minutes, frequently driving sharp institutional volume and rapid price jumps into the bell. Intraday Short Covering: Day traders and short sellers closing out intraday positions before the bell forces quick buy-side pressure to prevent overnight gap risk. Options Gamma Hedging: Market makers rebalancing delta-neutral positions toward the end of the session can accelerate momentum in the underlying asset if key strike prices are broken. Power Hour Volume: Trading volume routinely spikes during the final hour as funds align capital allocations before liquidity dries up post-market. $UMAC $PFE $MRNA

0 · Reply

Market Cap	152.69B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	8.79
Forward PE	9.00
Profit Margin	12.42%
Debt to Equity Ratio	0.74

Volume	23,174,100
Avg Vol	44,246,344
Day's Range	N/A - N/A
Shares Out	5.70B
Stochastic %K	84%
Beta	0.34
Analysts	Sell
Price Target	$28.60